Topic

Washington

A collection of 489 issues

How to Get Imbruvica (Ibrutinib) Covered by UnitedHealthcare in Washington: Prior Authorization, Appeals, and Templates

Answer Box: Getting Imbruvica Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization for Imbruvica (ibrutinib) but doesn't mandate step therapy for CLL, SLL, or Waldenström macroglobulinemia. The fastest path: (1) Submit complete PA with pathology, diagnosis, and treatment history; (2) If denied, file internal appeal within 180
5 min read

Myths vs. Facts: Getting Ultomiris (Ravulizumab) Covered by UnitedHealthcare in Washington

Answer Box: Getting Ultomiris Covered by UnitedHealthcare in Washington Eligibility: UnitedHealthcare requires prior authorization for Ultomiris (ravulizumab) with step therapy—typically trying eculizumab first. Fastest path: Submit complete PA documentation including diagnosis confirmation (PNH flow cytometry, AChR+ for gMG, AQP4+ for NMOSD), vaccination records, and prior therapy failures. First step
5 min read

Renewing Jaypirca (Pirtobrutinib) Coverage with Humana in Washington: 2025 Requirements & Timeline

Quick Answer: Renewing Your Jaypirca Coverage Humana requires annual prior authorization renewal for Jaypirca (pirtobrutinib). Start the renewal process 60-90 days before your current authorization expires. You'll need updated clinical documentation showing continued disease response or stability, absence of unacceptable toxicity, and ongoing medical necessity. Submit through Humana&
6 min read

How to Get Besponsa (Inotuzumab Ozogamicin) Covered by Humana in Washington: Complete Decision Tree & Appeals Guide

Answer Box: Your Path to Besponsa Coverage Getting Besponsa (inotuzumab ozogamicin) covered by Humana in Washington requires meeting specific criteria for relapsed/refractory CD22-positive ALL. Most approvals happen within 72 hours if you submit complete documentation upfront. Your first step today: Confirm CD22-positive status via flow cytometry and gather prior
6 min read